NSCLC Patient Baseline Characteristics on Immune Checkpoint Inhibitor Therapy

5.5 KB of baseline demographic and treatment data for patients with non-small cell lung cancer receiving immune checkpoint inhibitor-based therapy and healthy controls, authored by Lilia Cinti and last updated on May 15, 2026. The dataset is available in XLS format under a CC-BY-4.0 license.

Use Cases

• Compare baseline demographics between NSCLC patients on ICI therapy and healthy controls based on the described patient groups.
• Analyze treatment characteristics for NSCLC patients receiving immune checkpoint inhibitors as described in the dataset title.
• Study the composition of clinical cohorts for NSCLC immunotherapy research based on the provided baseline data.

Strengths

• Data is licensed under the permissive CC-BY-4.0 license for broad reuse.
• The dataset is focused on a specific clinical context: NSCLC patients on ICI therapy.

Limitations

• The dataset is very small at 5.5 KB, indicating limited scope and likely a small number of records.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.

Provenance

Source

Lilia Cinti

Freshness

Last updated 2026-05-15 17:40:40; freshness should be verified.